var data={"title":"Postabortion contraception","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Postabortion contraception</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/postabortion-contraception/contributors\" class=\"contributor contributor_credentials\">Andrew M Kaunitz, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/postabortion-contraception/contributors\" class=\"contributor contributor_credentials\">Courtney A Schreiber, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/postabortion-contraception/contributors\" class=\"contributor contributor_credentials\">Kristen Eckler, MD, FACOG</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/postabortion-contraception/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Dec 19, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H3096889459\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Contraceptive selection requires consideration of patient preferences and medical factors. For women who have undergone an abortion and desire contraception, additional issues include when to start the method and whether or not back-up contraception is necessary. Prompt initiation of postabortion contraception increases utilization and continuation and thus reduces the risk of future unintended pregnancy.</p><p>This topic will review contraception issues specific to women who experience first- or second-trimester abortion (typically &lt;24 weeks of gestation). Discussions on contraceptive counseling and selection and postpartum contraception are presented separately. (See <a href=\"topic.htm?path=contraceptive-counseling-and-selection\" class=\"medical medical_review\">&quot;Contraceptive counseling and selection&quot;</a> and <a href=\"topic.htm?path=postpartum-contraception-initiation-and-methods\" class=\"medical medical_review\">&quot;Postpartum contraception: Initiation and methods&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4143749050\"><span class=\"h1\">WHEN TO START POSTABORTION CONTRACEPTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The first ovulation postabortion occurs between a mean of 21 to 29 days after the procedure with a reported range of 8 to 103 days [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/1,2\" class=\"abstract_t\">1,2</a>]. As the resumption of ovulation can be rapid and unpredictable, we advise women who desire contraception to begin the method at the same time the abortion occurs (ie, immediate start).</p><p>Advantages of immediate initiation of contraception include that the woman is known not to be pregnant, an additional visit is not required, and the woman leaves with a contraceptive plan in place, although a plan to use condoms or short-acting reversible contraceptives is not likely to be as reliable as immediate initiation of long-acting reversible contraception. In a retrospective cohort study that compared women who needed an additional visit to initiate the intrauterine device or depot <a href=\"topic.htm?path=medroxyprogesterone-acetate-drug-information\" class=\"drug drug_general\">medroxyprogesterone acetate</a> injection with those who had immediate access, women with same-day access had significantly fewer subsequent abortions and births within 12 months and were more likely to use an effective or highly effective contraceptive (<a href=\"image.htm?imageKey=OBGYN%2F57795\" class=\"graphic graphic_figure graphicRef57795 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/3\" class=\"abstract_t\">3</a>]. (See <a href=\"topic.htm?path=contraceptive-counseling-and-selection#H110788275\" class=\"medical medical_review\">&quot;Contraceptive counseling and selection&quot;, section on 'Reduce unintended pregnancy'</a> and <a href=\"#H4025426071\" class=\"local\">'Long-acting reversible contraception'</a> below.)</p><p class=\"headingAnchor\" id=\"H272060030\"><span class=\"h1\">CONTRACEPTIVE OPTIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Postabortion women can safely use any contraceptive option that is compatible with their medical comorbidities as presented in the <a href=\"https://www.cdc.gov/reproductivehealth/unintendedpregnancy/pdf/legal_summary-chart_english_final_tag508.pdf&amp;token=JA/M3ckr+EtDMI44YR3ItnPOXjqYOZpPMK06Z5AI1lNPl1EybPp0UTI/qT1mevI2a0BCfuWQ9QTqLeCJ3cTvd4/QXJGAU72FUcVdMr2gbKOaKharuWoWe6/KV1LW93zxkZoZsBguhItofnzdFYnlmg==&amp;TOPIC_ID=109209\" target=\"_blank\" class=\"external\">Centers for Disease Control and Prevention Medical Eligibility Criteria for Contraceptive Use, 2016</a> [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/4\" class=\"abstract_t\">4</a>].</p><p class=\"headingAnchor\" id=\"H4025426071\"><span class=\"h2\">Long-acting reversible contraception</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Long-acting reversible contraception (LARC) has a low failure rate, high continuation rate, and high ease of use (<a href=\"image.htm?imageKey=OBGYN%2F70218\" class=\"graphic graphic_table graphicRef70218 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/4-6\" class=\"abstract_t\">4-6</a>]. LARC includes the <a href=\"topic.htm?path=copper-intrauterine-device-drug-information\" class=\"drug drug_general\">copper intrauterine device</a> (IUD), levonorgestrel-releasing IUDs, and the <a href=\"topic.htm?path=etonogestrel-implant-drug-information\" class=\"drug drug_general\">etonogestrel implant</a>. In a prospective study comparing subsequent abortion rates for women electing different types of contraception, women using LARC had significantly fewer abortions during the two years of follow-up compared with women using shorter-acting methods, mainly oral contraceptive pills (6.5 versus 14.5 percent) [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/7\" class=\"abstract_t\">7</a>]. (See <a href=\"topic.htm?path=contraceptive-counseling-and-selection#H110788275\" class=\"medical medical_review\">&quot;Contraceptive counseling and selection&quot;, section on 'Reduce unintended pregnancy'</a> and <a href=\"topic.htm?path=contraceptive-counseling-and-selection#H3061967225\" class=\"medical medical_review\">&quot;Contraceptive counseling and selection&quot;, section on 'Role of long-acting contraceptives'</a>.)</p><p class=\"headingAnchor\" id=\"H2661568225\"><span class=\"h3\">Progestin-only implant</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The progestin-only <a href=\"topic.htm?path=etonogestrel-implant-drug-information\" class=\"drug drug_general\">etonogestrel implant</a> is 99 percent effective at preventing pregnancy (<a href=\"image.htm?imageKey=OBGYN%2F70218\" class=\"graphic graphic_table graphicRef70218 \">table 1</a>), has a high continuation rate [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/8,9\" class=\"abstract_t\">8,9</a>], and has no risks specific to postabortion women [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/4\" class=\"abstract_t\">4</a>]. The etonogestrel implant can be inserted after any type of abortion (induction, medication, spontaneous, or surgical) regardless of gestational age at pregnancy termination [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/6,10\" class=\"abstract_t\">6,10</a>]. The advantages, risks, and insertion technique are presented separately. (See <a href=\"topic.htm?path=etonogestrel-contraceptive-implant\" class=\"medical medical_review\">&quot;Etonogestrel contraceptive implant&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1085426315\"><span class=\"h3\">Intrauterine contraception</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Either copper or levonorgestrel-releasing IUDs can be inserted immediately after abortion in women with no evidence of uterine infection [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/4,11-14\" class=\"abstract_t\">4,11-14</a>]. Postabortion intrauterine contraception is 99 percent effective (<a href=\"image.htm?imageKey=OBGYN%2F70218\" class=\"graphic graphic_table graphicRef70218 \">table 1</a>), associated with fewer subsequent abortions, and associated with higher rates of continued use when compared with short-acting contraceptive methods [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/5,12,15-20\" class=\"abstract_t\">5,12,15-20</a>]. Immediate IUD insertion has been reported to reduce subsequent abortions by 50 to 70 percent compared with interval IUD insertion (ie, insertion at a follow-up visit), but immediate insertion is also associated with higher rates of expulsion than interval insertion [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/21-26\" class=\"abstract_t\">21-26</a>].</p><p>The <a href=\"https://www.cdc.gov/reproductivehealth/unintendedpregnancy/pdf/legal_summary-chart_english_final_tag508.pdf&amp;token=JA/M3ckr+EtDMI44YR3ItnPOXjqYOZpPMK06Z5AI1lNPl1EybPp0UTI/qT1mevI2a0BCfuWQ9QTqLeCJ3cTvd4/QXJGAU72FUcVdMr2gbKOaKharuWoWe6/KV1LW93zxkZoZsBguhItofnzdFYnlmg==&amp;TOPIC_ID=109209\" target=\"_blank\" class=\"external\">Centers for Disease Control and Prevention</a> lists no restrictions for IUD insertion after a first-trimester abortion and notes that &quot;the advantages generally outweigh theoretical or proven risks&quot; for IUD insertion after a second-trimester abortion [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/4\" class=\"abstract_t\">4</a>]. The rationale for this latter recommendation comes from two meta-analyses reporting that the risk of IUD expulsion increased following second- versus first-trimester abortion and later versus earlier first-trimester abortion, although the selected trials and studies included IUD types that are no longer commonly used [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/25,27\" class=\"abstract_t\">25,27</a>]. The method of abortion does not appear to affect the expulsion rate. In trials comparing IUD expulsion after medication or surgical abortion, the rates of IUD expulsion varied from 4 to 11 percent [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/14,28,29\" class=\"abstract_t\">14,28,29</a>]. For comparison, the baseline expulsion rate in nonpregnant women ranges from 2 to 10 percent during the first year of use [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/6\" class=\"abstract_t\">6</a>]. (See <a href=\"topic.htm?path=intrauterine-contraception-management-of-side-effects-and-complications#H3108373607\" class=\"medical medical_review\">&quot;Intrauterine contraception: Management of side effects and complications&quot;, section on 'Expulsion'</a>.)</p><p>The characteristics, benefits, and adverse effects of IUDs are presented separately. (See <a href=\"topic.htm?path=intrauterine-contraception-candidates-and-device-selection\" class=\"medical medical_review\">&quot;Intrauterine contraception: Candidates and device selection&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2379508818\"><span class=\"h2\">Short-acting hormonal contraception</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Estrogen-progestin contraceptives (oral pill, transdermal patch, and vaginal ring) can be initiated after first- and second-trimester abortions [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/4,11\" class=\"abstract_t\">4,11</a>]. Short-acting progestin-only contraceptives (oral progestin-only pills, depot <a href=\"topic.htm?path=medroxyprogesterone-acetate-drug-information\" class=\"drug drug_general\">medroxyprogesterone acetate</a> injection) can be started immediately after an abortion, with no limits on gestational age [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11\" class=\"abstract_t\">11</a>]. At least one meta-analysis has reported that use of combined oral contraceptives following medication abortion reduced the duration and volume of vaginal bleeding [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/30\" class=\"abstract_t\">30</a>]. (See <a href=\"topic.htm?path=contraceptive-counseling-and-selection\" class=\"medical medical_review\">&quot;Contraceptive counseling and selection&quot;</a> and <a href=\"topic.htm?path=overview-of-the-use-of-estrogen-progestin-contraceptives\" class=\"medical medical_review\">&quot;Overview of the use of estrogen-progestin contraceptives&quot;</a> and <a href=\"topic.htm?path=progestin-only-pills-pops-for-contraception\" class=\"medical medical_review\">&quot;Progestin-only pills (POPs) for contraception&quot;</a> and <a href=\"topic.htm?path=depot-medroxyprogesterone-acetate-for-contraception\" class=\"medical medical_review\">&quot;Depot medroxyprogesterone acetate for contraception&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2086031116\"><span class=\"h2\">Barrier contraception</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Barrier methods include the diaphragm, cervical cap, sponge, and condoms (male and female). Advantages include contraception only when needed and lack of hormones. The main disadvantage for all barrier methods is lower efficacy compared with LARC and hormonal contraception (<a href=\"image.htm?imageKey=OBGYN%2F70218\" class=\"graphic graphic_table graphicRef70218 \">table 1</a>).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diaphragms are available in two forms: a round device that must be fit to the patient and a single-size device that does not require fitting (commercial name Caya). For women who were using a fitted diaphragm prior to pregnancy, the device should be refit if the abortion occurred at 14 weeks of gestation or later [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/31\" class=\"abstract_t\">31</a>]. Fitting cannot be performed properly until pregnancy-related cervical changes have regressed, which takes approximately two weeks after an abortion. Women who were using the single-size diaphragm do not need to make any changes. (See <a href=\"topic.htm?path=pericoital-contraception-diaphragm-cervical-cap-spermicide-and-sponge#H1666356771\" class=\"medical medical_review\">&quot;Pericoital contraception: Diaphragm, cervical cap, spermicide, and sponge&quot;, section on 'Diaphragm'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The FemCap is a cervical cap that is available in three sizes. The choice of size is determined by the woman&rsquo;s reproductive history. (See <a href=\"topic.htm?path=pericoital-contraception-diaphragm-cervical-cap-spermicide-and-sponge#H3911714417\" class=\"medical medical_review\">&quot;Pericoital contraception: Diaphragm, cervical cap, spermicide, and sponge&quot;, section on 'Cervical cap'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other barrier methods (male condom, female condom, sponge, and spermicidal agents) can be used as soon as coitus is resumed. (See <a href=\"topic.htm?path=male-condoms\" class=\"medical medical_review\">&quot;Male condoms&quot;</a> and <a href=\"topic.htm?path=female-condoms\" class=\"medical medical_review\">&quot;Female condoms&quot;</a> and <a href=\"topic.htm?path=pericoital-contraception-diaphragm-cervical-cap-spermicide-and-sponge#H553979233\" class=\"medical medical_review\">&quot;Pericoital contraception: Diaphragm, cervical cap, spermicide, and sponge&quot;, section on 'Spermicide'</a> and <a href=\"topic.htm?path=pericoital-contraception-diaphragm-cervical-cap-spermicide-and-sponge\" class=\"medical medical_review\">&quot;Pericoital contraception: Diaphragm, cervical cap, spermicide, and sponge&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H464857895\"><span class=\"h2\">Sterilization</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Women who desire sterilization can proceed with a laparoscopic method (eg, silastic band, bipolar electrocoagulation, titanium clip, or salpingectomy). Laparoscopic sterilization can be performed concurrently with a surgical abortion procedure as long as the timing of consent meets federal and state regulations. Hysteroscopic sterilization is contraindicated immediately following abortion. (See <a href=\"topic.htm?path=laparoscopic-female-sterilization\" class=\"medical medical_review\">&quot;Laparoscopic female sterilization&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1612628417\"><span class=\"h1\">HOW TO START POSTABORTION CONTRACEPTION</span></p><p class=\"headingAnchor\" id=\"H1828315435\"><span class=\"h2\">After surgical or induction abortion</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Women who undergo surgical (ie, dilation and evacuation) or induction abortion can start any medically appropriate contraceptive method on the day of the procedure and do not need a period of abstinence or back-up contraception [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11\" class=\"abstract_t\">11</a>]. Back-up contraception or a period of abstinence of seven days is advised for women who start contraception up to seven days from the procedure. </p><p>Management of women who start contraception more than seven days from a surgical or medication abortion is presented below. (See <a href=\"#H2228108341\" class=\"local\">'Delayed contraceptive start (&gt;7 days postabortion)'</a> below.)</p><p class=\"headingAnchor\" id=\"H1415354331\"><span class=\"h2\">After spontaneous or medication abortion</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The optimal contraceptive start time is less clear for spontaneous and medication abortion compared with surgical or induction abortion because the amount of time required for uterine evacuation is unpredictable. For women with a spontaneous abortion, the pregnancy may have lost viability days or weeks prior to the passage of tissue. In medication abortion, the woman must take two different medications at specified times. All of these issues can create confusion as to when to start contraception. (See <a href=\"topic.htm?path=spontaneous-abortion-management\" class=\"medical medical_review\">&quot;Spontaneous abortion: Management&quot;</a> and <a href=\"topic.htm?path=first-trimester-medication-abortion-termination-of-pregnancy\" class=\"medical medical_review\">&quot;First-trimester medication abortion (termination of pregnancy)&quot;</a>.)</p><p>For women who undergo medication or spontaneous abortion, the contraception start times and need for back-up contraception or a period of abstinence vary with the contraceptive method [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11\" class=\"abstract_t\">11</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Intrauterine device</strong> &ndash; Intrauterine devices can be inserted once the uterus is determined to be empty by either the clinical history or ultrasonography. (See <a href=\"topic.htm?path=spontaneous-abortion-management#H1898086605\" class=\"medical medical_review\">&quot;Spontaneous abortion: Management&quot;, section on 'Confirming complete evacuation'</a>.)</p><p/><p class=\"bulletIndent1\">No back-up contraception or abstinence period is needed following insertion of a copper IUD because it also functions as an emergency contraceptive [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11\" class=\"abstract_t\">11</a>]. In contrast, seven days of abstinence or back-up contraception are advised following insertion of a levonorgestrel-releasing IUD. (See <a href=\"topic.htm?path=intrauterine-contraception-candidates-and-device-selection\" class=\"medical medical_review\">&quot;Intrauterine contraception: Candidates and device selection&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=etonogestrel-implant-drug-information\" class=\"drug drug_general\">Etonogestrel implant</a> &ndash; For women undergoing medication abortion, the etonogestrel implant can be inserted on the day of <a href=\"topic.htm?path=mifepristone-drug-information\" class=\"drug drug_general\">mifepristone</a> administration [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11,32,33\" class=\"abstract_t\">11,32,33</a>]. If the implant is placed more than three days after mifepristone administration, back-up contraception or abstinence is required for an additional seven days [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/34\" class=\"abstract_t\">34</a>]. (See <a href=\"topic.htm?path=first-trimester-medication-abortion-termination-of-pregnancy\" class=\"medical medical_review\">&quot;First-trimester medication abortion (termination of pregnancy)&quot;</a>.)</p><p/><p class=\"bulletIndent1\">For women who have a spontaneous abortion, the <a href=\"topic.htm?path=etonogestrel-implant-drug-information\" class=\"drug drug_general\">etonogestrel implant</a> can be inserted after the abortion is completed. If implant insertion occurs more than three days following spontaneous abortion, back-up contraception or abstinence is required for an additional seven days [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11\" class=\"abstract_t\">11</a>]. (See <a href=\"topic.htm?path=spontaneous-abortion-management\" class=\"medical medical_review\">&quot;Spontaneous abortion: Management&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Depot </strong><a href=\"topic.htm?path=medroxyprogesterone-acetate-drug-information\" class=\"drug drug_general\">medroxyprogesterone acetate</a><strong> (DMPA) injection</strong> &ndash; DMPA injections can be initiated up to seven days after <a href=\"topic.htm?path=mifepristone-drug-information\" class=\"drug drug_general\">mifepristone</a> administration. An additional seven days of abstinence or back-up contraception are generally advised [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11\" class=\"abstract_t\">11</a>], but may be avoided if DMPA is initiated within three days of mifepristone use [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/34\" class=\"abstract_t\">34</a>]. For women who initiate DMPA on the day of mifepristone administration, the risk of ongoing pregnancy appears to be higher than for women who start the medication after the abortion is completed (3.6 versus 0.9 percent) [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/35\" class=\"abstract_t\">35</a>]. Thus, we counsel women that combined start of mifepristone and DMPA is more convenient but the medication abortion may be more likely to fail. (See <a href=\"topic.htm?path=depot-medroxyprogesterone-acetate-for-contraception\" class=\"medical medical_review\">&quot;Depot medroxyprogesterone acetate for contraception&quot;</a>.)</p><p/><p class=\"bulletIndent1\">DMPA injections can be initiated after a spontaneous abortion has been completed [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11\" class=\"abstract_t\">11</a>]. An additional seven days of abstinence or back-up contraception are advised.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Combined estrogen-progestin contraception</strong> &ndash; Combined estrogen-progestin contraception (ie, oral pill, patch, or vaginal ring) can be started within seven days of <a href=\"topic.htm?path=mifepristone-drug-information\" class=\"drug drug_general\">mifepristone</a> administration or spontaneous abortion [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11\" class=\"abstract_t\">11</a>]. Back-up contraception or abstinence is advised for an additional seven days.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Progestin-only pills (POPs)</strong> &ndash; POPs can be started within seven days of <a href=\"topic.htm?path=mifepristone-drug-information\" class=\"drug drug_general\">mifepristone</a> administration (for medication abortion) or spontaneous abortion [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11\" class=\"abstract_t\">11</a>]. In contrast with other methods, the Centers for Disease Control and Prevention advises two days of back-up contraception or abstinence because the rapid impact of the drug on cervical mucous takes more than two days unnecessary. However, we often advise seven days of back-up or abstinence to keep the recommendations simple and consistent across the methods. (See <a href=\"topic.htm?path=progestin-only-pills-pops-for-contraception#H407447879\" class=\"medical medical_review\">&quot;Progestin-only pills (POPs) for contraception&quot;, section on 'Initiation'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2228108341\"><span class=\"h1\">DELAYED CONTRACEPTIVE START (&gt;7 DAYS POSTABORTION)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For women who delay starting contraception for more than seven days from the abortion and present after having had unprotected sexual activity, we exclude pregnancy and assess the need for emergency contraception.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Exclude pregnancy &ndash; A new pregnancy is excluded by history (<a href=\"image.htm?imageKey=OBGYN%2F67567\" class=\"graphic graphic_table graphicRef67567 \">table 2</a>) or laboratory testing. Human chorionic gonadotropin (hCG) levels will typically take two to four weeks, but sometimes longer, to resolve after abortion. Of note, hCG levels are highest in the first trimester and therefore may take longer to resolve after a first-trimester abortion compared with a later gestation [<a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/36,37\" class=\"abstract_t\">36,37</a>]. If pregnancy testing is positive in this setting, the woman is encouraged to use back-up contraception (eg, condom) while serial quantitative serum hCG levels are assessed. If levels are clearly declining, the desired method of contraception can be started. (See <a href=\"topic.htm?path=overview-of-the-postpartum-period-physiology-complications-and-maternal-care#H10\" class=\"medical medical_review\">&quot;Overview of the postpartum period: Physiology, complications, and maternal care&quot;, section on 'Reproductive hormones'</a> and <a href=\"topic.htm?path=spontaneous-abortion-management\" class=\"medical medical_review\">&quot;Spontaneous abortion: Management&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Emergency contraception &ndash; We assess the need for emergency contraception when women present for start of contraception after resumption of sexual activity. In addition, for women who are uncertain about their contraceptive choice at the time of abortion, we review use and access to emergency contraception, and provide a prescription if needed. Use of emergency contraception after unprotected intercourse is presented separately. (See <a href=\"topic.htm?path=emergency-contraception\" class=\"medical medical_review\">&quot;Emergency contraception&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H758257844\"><span class=\"h1\">COMPLICATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Contraceptive complications generally do not differ among postabortion or nonpregnant women. As discussed above, there may be an increased rate of IUD expulsion after late first-trimester or second-trimester abortions. (See <a href=\"#H1085426315\" class=\"local\">'Intrauterine contraception'</a> above.)</p><p class=\"headingAnchor\" id=\"H347305313\"><span class=\"h1\">RESOURCES FOR CLINICIANS AND PATIENTS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"http://www.cdc.gov/&amp;token=mjmpv7xMHRIW2nr+3NCnsS2w2f795le/W5BejjZJaFc=&amp;TOPIC_ID=109209\" target=\"_blank\" class=\"external\">Centers for Disease Control and Prevention</a> &ndash; Provides free access to its <a href=\"http://www.cdc.gov/reproductivehealth/contraception/pdf/summary-chart-us-medical-eligibility-criteria_508tagged.pdf&amp;token=jEVGVo6WqsDq698K1C6vDPPjIqTfzg54vW4qWS3doblDMO+X3NN/ro6R0xwK/I6IOwBh6DyNhV/q6vrv3T8nCaRCrZsEC+Wz9FPYFmXFzWEhd9uzeVTKQGeWKf6mT23Z1X5qsRVoFq27I5l+8ZoObQ==&amp;TOPIC_ID=109209\" target=\"_blank\" class=\"external\">Medical Eligibility Criteria</a> and <a href=\"http://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6504.pdf&amp;token=mjmpv7xMHRIW2nr+3NCnsRRMR0IbKy23mk05qdX4YkRc8aJbpe1S4Ga2DOSAtgX5g3hShN2d9BpkHvGmgRRmdA==&amp;TOPIC_ID=109209\" target=\"_blank\" class=\"external\">Selected Practice Recommendations</a> for contraceptive use.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"https://www.plannedparenthood.org/learn/birth-control&amp;token=Eoe67EnC47inw3CqzscFoFH6C0u6MFr/HO07FLdAAMI6v1KYwv3x2iWncZIAm1ej7D4lJBH9f9yDZ9pImgGI4Q==&amp;TOPIC_ID=109209\" target=\"_blank\" class=\"external\">Planned Parenthood</a> &ndash; Provides free information on abortion and contraceptive options for patients and health care providers.</p><p/><p class=\"headingAnchor\" id=\"H2296165006\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-contraception\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Contraception&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=birth-control-which-method-is-right-for-me-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Birth control; which method is right for me? (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H2955270709\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The first ovulation postabortion occurs between a mean of 21 to 29 days after the procedure with a reported range of 8 to 103 days. As the resumption of ovulation can be rapid and unpredictable, we advise women who desire contraception to begin the method at the same time as the abortion (ie, immediate start). Advantages of immediate start include that the woman is known not to be pregnant, an additional visit is not required, the woman has a reliable method in place prior to leaving the clinic, and unintended pregnancy is reduced.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Long-acting contraceptives (ie, copper or <a href=\"topic.htm?path=levonorgestrel-systemic-drug-information\" class=\"drug drug_general\">levonorgestrel</a> intrauterine devices or <a href=\"topic.htm?path=etonogestrel-implant-drug-information\" class=\"drug drug_general\">etonogestrel implant</a>) are the most-effective methods of contraception (<a href=\"image.htm?imageKey=OBGYN%2F70218\" class=\"graphic graphic_table graphicRef70218 \">table 1</a>) and have high continuation rates. (See <a href=\"#H4025426071\" class=\"local\">'Long-acting reversible contraception'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The <a href=\"topic.htm?path=etonogestrel-implant-drug-information\" class=\"drug drug_general\">etonogestrel implant</a> can be inserted immediately after any type of abortion regardless of gestational age. (See <a href=\"#H2661568225\" class=\"local\">'Progestin-only implant'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Either copper or levonorgestrel-releasing IUDs can be inserted immediately after abortion in women with no evidence of uterine infection. The main disadvantage of immediate IUD insertion after second-trimester dilation and evacuation is a somewhat higher risk of IUD expulsion compared with interval insertion at a follow-up visit. (See <a href=\"#H1085426315\" class=\"local\">'Intrauterine contraception'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Short-acting estrogen-progestin contraceptives (oral pill, transdermal patch, and vaginal ring) and progestin-only contraceptives (oral progestin-only pills, depot <a href=\"topic.htm?path=medroxyprogesterone-acetate-drug-information\" class=\"drug drug_general\">medroxyprogesterone acetate</a> injection) can be initiated immediately after abortion. Estrogen-progestin contraceptives may reduce the duration and volume of vaginal bleeding after medication abortion. (See <a href=\"#H2379508818\" class=\"local\">'Short-acting hormonal contraception'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Barrier methods, including the diaphragm, cervical cap, sponge, and condoms (male and female), provide contraception only when needed and do not have hormones but are less effective compared with long-acting reversible and hormonal contraception (<a href=\"image.htm?imageKey=OBGYN%2F70218\" class=\"graphic graphic_table graphicRef70218 \">table 1</a>). Diaphragms may need to be refitted two weeks after the abortion if the event occurred at 14 weeks of gestation or greater. Women using cervical caps may need their cap size adjusted. (See <a href=\"#H2086031116\" class=\"local\">'Barrier contraception'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Laparoscopic sterilization (eg, silastic band, bipolar electrocoagulation, titanium clip, or salpingectomy) can be performed following any type of abortion and can be done concurrently with a surgical abortion procedure. Hysteroscopic sterilization is contraindicated immediately after abortion. (See <a href=\"#H464857895\" class=\"local\">'Sterilization'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Women who undergo surgical (eg, dilation and evacuation) or induction abortion can start any medically appropriate contraceptive method on the day of the procedure (ie, immediate start) and do not need a period of abstinence or back-up contraception. Women who do delay contraceptive start to within seven days of the abortion are advised to use a back-up contraceptive or perform abstinence for an additional seven days. (See <a href=\"#H1828315435\" class=\"local\">'After surgical or induction abortion'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Women who have a medication or spontaneous abortion are advised to start contraception within seven days of the abortion and are also advised to continue back-up method or abstinence for an additional seven days. (See <a href=\"#H1415354331\" class=\"local\">'After spontaneous or medication abortion'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For women who present more than seven days from an abortion of any kind and who have had unprotected sexual activity, the possibility of pregnancy should be excluded with history (<a href=\"image.htm?imageKey=OBGYN%2F67567\" class=\"graphic graphic_table graphicRef67567 \">table 2</a>) or laboratory testing, and the need for emergency contraception should be assessed. (See <a href=\"#H2228108341\" class=\"local\">'Delayed contraceptive start (&gt;7 days postabortion)'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Contraceptive complications generally do not differ among postabortion or nonpregnant women, except there appears to be a slightly increased rate of IUD expulsion after late first-trimester or second-trimester abortions. (See <a href=\"#H758257844\" class=\"local\">'Complications'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/1\" class=\"nounderline abstract_t\">Stoddard A, Eisenberg DL. Controversies in family planning: timing of ovulation after abortion and the conundrum of postabortion intrauterine device insertion. Contraception 2011; 84:119.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/2\" class=\"nounderline abstract_t\">Schreiber CA, Sober S, Ratcliffe S, Creinin MD. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception 2011; 84:230.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/3\" class=\"nounderline abstract_t\">Langston AM, Joslin-Roher SL, Westhoff CL. Immediate postabortion access to IUDs, implants and DMPA reduces repeat pregnancy within 1 year in a New York City practice. Contraception 2014; 89:103.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/4\" class=\"nounderline abstract_t\">Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016; 65:1.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/5\" class=\"nounderline abstract_t\">American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices. Obstet Gynecol 2011; 118:184.</a></li><li class=\"breakAll\">Hatcher RA, Trussel RA, Nelson AL, et al. Contraceptive Technology, 20th ed, Ardent Media, New York 2011.</li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/7\" class=\"nounderline abstract_t\">Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol 2012; 206:37.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/8\" class=\"nounderline abstract_t\">Tocce KM, Sheeder JL, Teal SB. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference? Am J Obstet Gynecol 2012; 206:481.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/9\" class=\"nounderline abstract_t\">Kamel H, Navi BB, Sriram N, et al. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med 2014; 370:1307.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/10\" class=\"nounderline abstract_t\">Park J, Robinson N, Wessels U, et al. Progestin-based contraceptive on the same day as medical abortion. Int J Gynaecol Obstet 2016; 133:217.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/11\" class=\"nounderline abstract_t\">Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep 2016; 65:1.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/12\" class=\"nounderline abstract_t\">Pakarinen P, Toivonen J, Luukkainen T. Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up. Contraception 2003; 68:31.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/13\" class=\"nounderline abstract_t\">Ortayli N, Bulut A, Sahin T, Sivin I. Immediate postabortal contraception with the levonorgestrel intrauterine device, Norplant, and traditional methods. Contraception 2001; 63:309.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/14\" class=\"nounderline abstract_t\">Betstadt SJ, Turok DK, Kapp N, et al. Intrauterine device insertion after medical abortion. Contraception 2011; 83:517.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/15\" class=\"nounderline abstract_t\">Ogburn JA, Espey E, Stonehocker J. Barriers to intrauterine device insertion in postpartum women. Contraception 2005; 72:426.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/16\" class=\"nounderline abstract_t\">Fox MC, Oat-Judge J, Severson K, et al. Immediate placement of intrauterine devices after first and second trimester pregnancy termination. Contraception 2011; 83:34.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/17\" class=\"nounderline abstract_t\">Reeves MF, Smith KJ, Creinin MD. Contraceptive effectiveness of immediate compared with delayed insertion of intrauterine devices after abortion: a decision analysis. Obstet Gynecol 2007; 109:1286.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/18\" class=\"nounderline abstract_t\">Drey EA, Reeves MF, Ogawa DD, et al. Insertion of intrauterine contraceptives immediately following first- and second-trimester abortions. Contraception 2009; 79:397.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/19\" class=\"nounderline abstract_t\">Cremer M, Bullard KA, Mosley RM, et al. Immediate vs. delayed post-abortal copper T 380A IUD insertion in cases over 12 weeks of gestation. Contraception 2011; 83:522.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/20\" class=\"nounderline abstract_t\">Black A, Guilbert E, Costescu D, et al. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception. J Obstet Gynaecol Can 2016; 38:182.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/21\" class=\"nounderline abstract_t\">Birgisson NE, Zhao Q, Secura GM, et al. Preventing unintended pregnancy: The contraceptive CHOICE project in review. J Womens Health (Larchmt) 2015; 24:349.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/22\" class=\"nounderline abstract_t\">Goodman S, Hendlish SK, Reeves MF, Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception 2008; 78:143.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/23\" class=\"nounderline abstract_t\">Heikinheimo O, Gissler M, Suhonen S. Can the outcome of the next pregnancy be predicted at the time of induced abortion? Hum Reprod 2009; 24:820.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/24\" class=\"nounderline abstract_t\">Pohjoranta E, Mentula M, Gissler M, et al. Provision of intrauterine contraception in association with first trimester induced abortion reduces the need of repeat abortion: first-year results of a randomized controlled trial. Hum Reprod 2015; 30:2539.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/25\" class=\"nounderline abstract_t\">Okusanya BO, Oduwole O, Effa EE. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev 2014; :CD001777.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/26\" class=\"nounderline abstract_t\">Korjamo R, Mentula M, Heikinheimo O. Expulsions and adverse events following immediate and later insertion of a levonorgestrel-releasing intrauterine system after medical termination of late first- and second-trimester pregnancy: a randomised controlled trial. BJOG 2017; 124:1965.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/27\" class=\"nounderline abstract_t\">Steenland MW, Tepper NK, Curtis KM, Kapp N. Intrauterine contraceptive insertion postabortion: a systematic review. Contraception 2011; 84:447.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/28\" class=\"nounderline abstract_t\">Bednarek PH, Creinin MD, Reeves MF, et al. Immediate versus delayed IUD insertion after uterine aspiration. N Engl J Med 2011; 364:2208.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/29\" class=\"nounderline abstract_t\">Shimoni N, Davis A, Westhoff C. Can ultrasound predict IUD expulsion after medical abortion? Contraception 2014; 89:434.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/30\" class=\"nounderline abstract_t\">Che Y, Liu X, Zhang B, Cheng L. Oral contraception following abortion: A systematic review and meta-analysis. Medicine (Baltimore) 2016; 95:e3825.</a></li><li class=\"breakAll\">www.plannedparenthood.org (Accessed on August 01, 2016).</li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/32\" class=\"nounderline abstract_t\">Raymond EG, Weaver MA, Tan YL, et al. Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol 2016; 127:306.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/33\" class=\"nounderline abstract_t\">Hognert H, Kopp Kallner H, Cameron S, et al. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial. Hum Reprod 2016; 31:2484.</a></li><li class=\"breakAll\">Creinin M, August 2016, personal communication.</li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/35\" class=\"nounderline abstract_t\">Raymond EG, Weaver MA, Louie KS, et al. Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol 2016; 128:739.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/36\" class=\"nounderline abstract_t\">Batzer FR. Hormonal evaluation of early pregnancy. Fertil Steril 1980; 34:1.</a></li><li><a href=\"https://www.uptodate.com/contents/postabortion-contraception/abstract/37\" class=\"nounderline abstract_t\">Cole LA. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem 1997; 43:2233.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 109209 Version 11.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H2955270709\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H3096889459\" id=\"outline-link-H3096889459\">INTRODUCTION</a></li><li><a href=\"#H4143749050\" id=\"outline-link-H4143749050\">WHEN TO START POSTABORTION CONTRACEPTION</a></li><li><a href=\"#H272060030\" id=\"outline-link-H272060030\">CONTRACEPTIVE OPTIONS</a><ul><li><a href=\"#H4025426071\" id=\"outline-link-H4025426071\">Long-acting reversible contraception</a><ul><li><a href=\"#H2661568225\" id=\"outline-link-H2661568225\">- Progestin-only implant</a></li><li><a href=\"#H1085426315\" id=\"outline-link-H1085426315\">- Intrauterine contraception</a></li></ul></li><li><a href=\"#H2379508818\" id=\"outline-link-H2379508818\">Short-acting hormonal contraception</a></li><li><a href=\"#H2086031116\" id=\"outline-link-H2086031116\">Barrier contraception</a></li><li><a href=\"#H464857895\" id=\"outline-link-H464857895\">Sterilization</a></li></ul></li><li><a href=\"#H1612628417\" id=\"outline-link-H1612628417\">HOW TO START POSTABORTION CONTRACEPTION</a><ul><li><a href=\"#H1828315435\" id=\"outline-link-H1828315435\">After surgical or induction abortion</a></li><li><a href=\"#H1415354331\" id=\"outline-link-H1415354331\">After spontaneous or medication abortion</a></li></ul></li><li><a href=\"#H2228108341\" id=\"outline-link-H2228108341\">DELAYED CONTRACEPTIVE START (&gt;7 DAYS POSTABORTION)</a></li><li><a href=\"#H758257844\" id=\"outline-link-H758257844\">COMPLICATIONS</a></li><li><a href=\"#H347305313\" id=\"outline-link-H347305313\">RESOURCES FOR CLINICIANS AND PATIENTS</a></li><li><a href=\"#H2296165006\" id=\"outline-link-H2296165006\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H644935464\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H2955270709\" id=\"outline-link-H2955270709\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"OBGYN/109209|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/57795\" class=\"graphic graphic_figure\">- Comparison of effectiveness of contraceptive methods</a></li></ul></li><li><div id=\"OBGYN/109209|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=OBGYN/70218\" class=\"graphic graphic_table\">- Pregnancy rate during first year of contraception</a></li><li><a href=\"image.htm?imageKey=OBGYN/67567\" class=\"graphic graphic_table\">- Questions used to assess possibility of pregnancy</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=contraceptive-counseling-and-selection\" class=\"medical medical_review\">Contraceptive counseling and selection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=depot-medroxyprogesterone-acetate-for-contraception\" class=\"medical medical_review\">Depot medroxyprogesterone acetate for contraception</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=emergency-contraception\" class=\"medical medical_review\">Emergency contraception</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etonogestrel-contraceptive-implant\" class=\"medical medical_review\">Etonogestrel contraceptive implant</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=female-condoms\" class=\"medical medical_review\">Female condoms</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=first-trimester-medication-abortion-termination-of-pregnancy\" class=\"medical medical_review\">First-trimester medication abortion (termination of pregnancy)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intrauterine-contraception-candidates-and-device-selection\" class=\"medical medical_review\">Intrauterine contraception: Candidates and device selection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intrauterine-contraception-management-of-side-effects-and-complications\" class=\"medical medical_review\">Intrauterine contraception: Management of side effects and complications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=laparoscopic-female-sterilization\" class=\"medical medical_review\">Laparoscopic female sterilization</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=male-condoms\" class=\"medical medical_review\">Male condoms</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-postpartum-period-physiology-complications-and-maternal-care\" class=\"medical medical_review\">Overview of the postpartum period: Physiology, complications, and maternal care</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-use-of-estrogen-progestin-contraceptives\" class=\"medical medical_review\">Overview of the use of estrogen-progestin contraceptives</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=birth-control-which-method-is-right-for-me-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Birth control; which method is right for me? (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pericoital-contraception-diaphragm-cervical-cap-spermicide-and-sponge\" class=\"medical medical_review\">Pericoital contraception: Diaphragm, cervical cap, spermicide, and sponge</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=postpartum-contraception-initiation-and-methods\" class=\"medical medical_review\">Postpartum contraception: Initiation and methods</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=progestin-only-pills-pops-for-contraception\" class=\"medical medical_review\">Progestin-only pills (POPs) for contraception</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-contraception\" class=\"medical medical_society_guidelines\">Society guideline links: Contraception</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=spontaneous-abortion-management\" class=\"medical medical_review\">Spontaneous abortion: Management</a></li></ul></div></div>","javascript":null}